Bladder Cancer from Detection to Treatment
What Is Bladder Cancer?
Bladder cancer begins in the cells lining the inside of the bladder - the organ that stores urine.
The most common type is Urothelial | Transitional Cell | Carcinoma.
It is often detected early because symptoms like blood in the urine appear quickly.
Bladder cancer begins in the cells lining the inside of the bladder - the organ that stores urine.
The most common type is Urothelial | Transitional Cell | Carcinoma.
It is often detected early because symptoms like blood in the urine appear quickly.
1. Initial Detection / Screening
Common Symptoms:
Blood in urine | hematuria.
Painful urination | dysuria.
Frequent urination or urgency.
Pelvic or lower back pain.
Fatigue or weight loss in later stages.
Screening:
There is no routine population screening for bladder cancer.
High-risk individuals may have urine cytology or cystoscopy periodically.
Common Symptoms:
Blood in urine | hematuria.
Painful urination | dysuria.
Frequent urination or urgency.
Pelvic or lower back pain.
Fatigue or weight loss in later stages.
Screening:
There is no routine population screening for bladder cancer.
High-risk individuals may have urine cytology or cystoscopy periodically.
2. Diagnostic Testing
Urine Tests
Urinalysis
Urine cytology
Urine tumor marker tests
Imaging Studies
Ultrasound
CT Urography / Intravenous Urogram
MRI
Cystoscopy
A thin camera | cystoscope | is inserted through the urethra to visually inspect the bladder.
Biopsy or transurethral resection is performed during cystoscopy to remove tumor tissue for histological analysis.
Urine Tests
Urinalysis
Urine cytology
Urine tumor marker tests
Imaging Studies
Ultrasound
CT Urography / Intravenous Urogram
MRI
Cystoscopy
A thin camera | cystoscope | is inserted through the urethra to visually inspect the bladder.
Biopsy or transurethral resection is performed during cystoscopy to remove tumor tissue for histological analysis.
3. Pathology and Staging
Histological Types
Urothelial carcinoma
Squamous cell carcinoma
Adenocarcinoma
Tumor Grading
Low-grade:
slower growth, less likely to invade.
High-grade:
aggressive, more likely to invade or spread.
Staging - TNM System
Ta: Non-invasive papillary tumor | inner lining only.
T1: Invades connective tissue under the lining.
T2: Invades muscle layer.
T3: Extends into fatty tissue outside the bladder.
T4: Invades nearby organs | prostate, uterus, pelvic wall.
N/M: Lymph node or distant metastasis involvement.
Grouped Stages
Non–muscle-invasive:
Ta, T1, carcinoma in situ.
Muscle-invasive:
T2 and above.
Metastatic:
cancer spread beyond bladder.
Histological Types
Urothelial carcinoma
Squamous cell carcinoma
Adenocarcinoma
Tumor Grading
Low-grade:
slower growth, less likely to invade.
High-grade:
aggressive, more likely to invade or spread.
Staging - TNM System
Ta: Non-invasive papillary tumor | inner lining only.
T1: Invades connective tissue under the lining.
T2: Invades muscle layer.
T3: Extends into fatty tissue outside the bladder.
T4: Invades nearby organs | prostate, uterus, pelvic wall.
N/M: Lymph node or distant metastasis involvement.
Grouped Stages
Non–muscle-invasive:
Ta, T1, carcinoma in situ.
Muscle-invasive:
T2 and above.
Metastatic:
cancer spread beyond bladder.
4. Treatment Options
➛ Non–Muscle-Invasive Bladder Cancer
Transurethral Resection of Bladder Tumor
Removes tumor through cystoscope.
Diagnostic and therapeutic.
Intravesical Therapy
Medicine placed directly into bladder via catheter.
Mitomycin C or Bacillus Calmette - Guérin used to kill remaining cancer cells and prevent recurrence.
BCG is most effective for high-risk NMIBC.
Regular Cystoscopic Surveillance
Every 3-6 months initially, then yearly.
➛ Muscle-Invasive Bladder Cancer
Radical Cystectomy
Removal of entire bladder and nearby lymph nodes.
In men:
often includes prostate and seminal vesicles.
In women:
uterus, ovaries, and part of vagina may be removed.
Urinary diversion created.
Chemotherapy
Neoadjuvant - before surgery
Adjuvant - after surgery
Bladder-Preserving Therapy
Trimodal therapy: TURBT + chemotherapy + radiation therapy
➛ Metastatic or Advanced Disease
Systemic chemotherapy
Cisplatin-based regimens | MVAC or GC.
Immunotherapy
Pembrolizumab, Nivolumab, Atezolizumab
Targeted therapy
Erdafitinib for FGFR mutations.
Palliative radiation therapy
To relieve symptoms | pain, bleeding, obstruction.
➛ Non–Muscle-Invasive Bladder Cancer
Transurethral Resection of Bladder Tumor
Removes tumor through cystoscope.
Diagnostic and therapeutic.
Intravesical Therapy
Medicine placed directly into bladder via catheter.
Mitomycin C or Bacillus Calmette - Guérin used to kill remaining cancer cells and prevent recurrence.
BCG is most effective for high-risk NMIBC.
Regular Cystoscopic Surveillance
Every 3-6 months initially, then yearly.
➛ Muscle-Invasive Bladder Cancer
Radical Cystectomy
Removal of entire bladder and nearby lymph nodes.
In men:
often includes prostate and seminal vesicles.
In women:
uterus, ovaries, and part of vagina may be removed.
Urinary diversion created.
Chemotherapy
Neoadjuvant - before surgery
Adjuvant - after surgery
Bladder-Preserving Therapy
Trimodal therapy: TURBT + chemotherapy + radiation therapy
➛ Metastatic or Advanced Disease
Systemic chemotherapy
Cisplatin-based regimens | MVAC or GC.
Immunotherapy
Pembrolizumab, Nivolumab, Atezolizumab
Targeted therapy
Erdafitinib for FGFR mutations.
Palliative radiation therapy
To relieve symptoms | pain, bleeding, obstruction.
5. Follow-Up and Monitoring
Cystoscopy
Every 3-6 months for the first 2 years.
Every 6-12 months afterward.
Urine cytology and imaging:
CT or ultrasound
Periodically to monitor recurrence or metastasis.
Lifestyle changes:
Quit smoking.
Maintain hydration.
Avoid exposure to industrial chemicals | aromatic amines.
Cystoscopy
Every 3-6 months for the first 2 years.
Every 6-12 months afterward.
Urine cytology and imaging:
CT or ultrasound
Periodically to monitor recurrence or metastasis.
Lifestyle changes:
Quit smoking.
Maintain hydration.
Avoid exposure to industrial chemicals | aromatic amines.
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page